Keynote I: Accelerating Innovation & Reimagining Health

This keynote examined how leadership, culture, and aligned incentives can accelerate medical innovation, drawing lessons from the rapid development of COVID 19 vaccines and their application to radiopharmaceutical therapies (RPTs). Participants explore current barriers to RPT adoption and emerging opportunities to expand access through regulatory flexibility, collaboration, and data driven care. The session concluded with a call to rebuild trust, reduce disparities, and enable faster, more equitable access to lifesaving therapies.

Target Audience

This meeting was designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, diagnostic radiologists,  radiation therapists, radiation dosimetrists, specialists, nuclear physicians and practice administrators. 

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Describe how leadership, organizational culture, and regulatory flexibility can accelerate medical innovation, using lessons from rapid COVID 19 vaccine development and their application to radiopharmaceutical therapies.
  • Discuss emerging opportunities and challenges in radiopharmaceutical therapies and their potential impact on patient access, clinical care, and health equity.
Course summary
Available credit: 
  • 0.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.00 Certificate of Attendance
    This activity was designated for 0.00 AMA PRA Category 1 Credit™.
Course opens: 
02/09/2026
Course expires: 
03/01/2028
Cost:
$0.00
Part of: 
2026 Multidisciplinary Radiopharmaceutical Therapy Symposium onDemand
Rating: 
0

 

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 0.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.00 Certificate of Attendance
    This activity was designated for 0.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.